Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
TORONTO, Feb. 26, 2014 /CNW/ - The following B-Roll is available by Video On-Demand web download:
STORY SUMMARY: Novartis announced today that Bexsero® (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection. Bexsero® is the first broad-coverage vaccine to help protect against MenB disease. Prior to Bexsero®, vaccines were only available to help protect against meningococcal strains A, C, W and Y.
WEB Video Preview and Download link:
|TIME OF POSTING:||Available Now|
|DATE OF POSTING:||02/26/2014|
All video can be viewed by clicking on the link. Broadcast quality video is available for download by accredited journalists. Please contact firstname.lastname@example.org for access.
STATIONS, FOR FURTHER INFORMATION, PLEASE CALL:
416 642 7893
For assistance with Video On-Demand, please contact CNW at email@example.com or (416) 863-5612.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct from our website to accredited journalists worldwide.
This material is offered for free and unrestricted news use.
CNW VIDEO SERVICES.
SOURCE Novartis Pharmaceuticals Canada Inc.
Video with caption: "Video: Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B (MenB) Now Available in Canada". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20140226_C7548_VIDEO_EN_37165.mp4&posterurl=http://photos.newswire.ca/images/20140226_C7548_PHOTO_EN_37165.jpg&clientName=Novartis%20Pharmaceuticals%20Canada%20Inc%2E&caption=Video%3A%20Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada&title=Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada&headline=Free%20VIDEO%20B%2DROLL%20AVAILABLE%20VIA%20CNW%20%2D%20Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada
©2012 PR Newswire. All Rights Reserved.